Effects of unripe Citrus hassaku fruits extract and its flavanone glycosides on blood fluidity.
The enhancement of blood fluidity may lead to improvements in skin problems resulting from unsmooth circulation or blood stagnation. Since a 50% ethanolic extract (CH-ext) obtained from unripe Citrus hassaku fruits may be a useful ingredient in skin-whitening cosmetics, the present study was designed to examine the effect of CH-ext on blood fluidity. CH-ext concentration-dependently inhibited in vitro collagen-induced rabbit platelet aggregation and in vitro polybrene-induced rat erythrocyte aggregation. The CH-ext showed in vitro fibrinolysis activity in fibrin plate assay. Activity-guided fractionation of the CH-ext using antiplatelet activity, inhibitory activity of erythrocyte aggregation, and fibrinolysis activity revealed that these activities of CH-ext were attributable to naringenin-7-glycoside (prunin). Successive oral administration of CH-ext to rats inhibited the lipopolysaccharide (LPS)-induced decrease of blood platelets and fibrinogen, and LPS-induced increase of fibrin degradation products (FDP) in LPS-induced disseminated intravascular coagulation (DIC) model rats. Effects of CH-ext on blood fluidity were analyzed by a micro channel array flow analyzer (MC-FAN). Preventive oral administration of CH-ext to rats showed dose-dependent reduction of the passage time of whole blood flow of the DIC model rats in comparison with that of the vehicle control rats. These results imply that CH-ext may have effects which improve effects on blood fluidity.
Itoh
Kimihisa
K
Faculty of Pharmacy, Kinki University, Japan.
Masuda
Megumi
M
Naruto
Shunsuke
S
Murata
Kazuya
K
Matsuda
Hideaki
H
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects; D002957:Citrus / Q000737:chemistry*; D003094:Collagen; D004305:Dose-Response Relationship, Drug; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D004912:Erythrocytes / Q000187:drug effects; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D044950:Flavanones / Q000494:pharmacology*; D005638:Fruit; D006027:Glycosides / Q000494:pharmacology*; D006401:Hematologic Agents / Q000494:pharmacology*; D006403:Hematologic Tests; D018056:Hemorheology / Q000187:drug effects; D008070:Lipopolysaccharides; D008297:Male; D010936:Plant Extracts / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar
D044950:Flavanones; D006027:Glycosides; D006401:Hematologic Agents; D008070:Lipopolysaccharides; D010936:Plant Extracts; D005337:Fibrin; D005340:Fibrinogen; D003094:Collagen; C005273:naringenin